insights_auto
Why is NVS up 2.45%?
Dive Deeperchevron_right
NVS:NYSE
Novartis AG
$145.90
arrow_upward
+2.45%(+3.49) 1D
Oct 14, 11:25:00 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVS...
Open
$144.35
High
$145.94
Low
$144.17
Mkt. cap
298.82B
Avg. vol.
2.40M
Volume
509.48K
Dividend
3.25%
Quarterly dividend
$1.19
Ex-dividend date
Mar 10, 2026
P/E ratio
22.04
52-wk high
$170.46
52-wk low
$121.57
EPS
$6.62
Beta
0.39
Shares outstanding
2.03B
No. of employees
75K
Open
$144.35
High
$145.94
Low
$144.17
Mkt. cap
298.82B
Avg. vol.
2.40M
Volume
509.48K
Dividend
3.25%
Quarterly dividend
$1.19
Ex-dividend date
Mar 10, 2026
P/E ratio
22.04
52-wk high
$170.46
52-wk low
$121.57
EPS
$6.62
Beta
0.39
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
ad-hoc-news.de
·
16 minutes ago
Bank of America keeps CHF 150.00 target for Novartis stock
Investing.com Canada
·
3 hours ago
MindWalk adds three executives from Pfizer, Novartis, Arbor By Investing.com
ad-hoc-news.de
·
5 hours ago
Erste Group raised its Novartis stock forecast to USD 9.24
News Corp
·
20 hours ago
Can a Spinoff Fix Johnson & Johnson’s Medtech Problem?
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com